Non-invasive home monitoring of asthma and COPD with a once daily breath test (Razor/Blade, Device/Test Strip) that measures airway inflammation via an exhaled biomarker.
Our solution combines a patented breathalyzer and digital solution to identify risk of attack up to 20 days before symptoms to enable simple and proactive interventions to prevent attacks. Proactively tailoring therapy based on the data reduces the risk by 50%.